News

June 22, 2020June 22, 2020

Stem Cell-related Abnormalities May Predict Recurrence in Crohn’s Disease

Crohn's Disease, News

Abnormalities in intestinal stem cell niches may predict recurrence in Crohn’s disease, a new study suggests. These irregularities may result from problems with mitochondria — the so-called powerhouse of ... Read more

June 15, 2020June 15, 2020

Scientists Find Variation in JAK2 Gene That Can Lead to IBD

News

Scientists have discovered a genetic variation in the janus kinase 2 (JAK2) gene — a gene involved in a signaling pathway implicated in other autoimmune diseases — that can ... Read more

June 9, 2020June 9, 2020

Nominations Now Open for Sherman Prizes Honoring Excellence in IBD

News

The Bruce and Cynthia Sherman Charitable Foundation is now accepting nominations for the 2020 Sherman Prizes, which recognize individuals working toward improving the lives of people with Crohn’s disease ... Read more

June 1, 2020June 1, 2020

UK Health Agency Recommends Stelara for Moderately to Severely Active Ulcerative Colitis

News

The U.K. National Institute for Health and Care Excellence (NICE) has recommended the use of Stelara (ustekinumab) to treat patients with moderately to severely active ulcerative colitis specifically in adults ... Read more

May 18, 2020May 18, 2020

Early Phase 2 Trial Data Support Safety, Efficacy of BBT-401 for Ulcerative Colitis

News, Ulcerative colitis

People with ulcerative colitis may benefit from the experimental oral therapy BBT-401, suggest early data from an ongoing Phase 2 clinical trial that also supports its good safety profile. BBT-401 ... Read more

May 11, 2020May 11, 2020

Entyvio At-home Injection Approved in Europe to Treat Adults With IBD

Crohn's Disease, News, Ulcerative colitis

The European Commission has approved a subcutaneous (under-the-skin) formulation of Entyvio (vedolizumab) for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). ... Read more

May 4, 2020May 4, 2020

Joint Study to Assess Effects of COVID-19 on Patients with IBD, Other Autoimmune Conditions

News

The Global Healthy Living Foundation (GHLF) has launched a study to evaluate the impact of the COVID-19 pandemic on patients with Crohn’s disease and ulcerative colitis, among other autoimmune ... Read more

April 20, 2020April 20, 2020

New Guidelines Issued on Treating IBD Patients During COVID-19 Pandemic

News

Leading experts have drafted new guidelines to aid gastroenterologists in the management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic, according to an American Gastroenterological Association (AGA) ... Read more

April 13, 2020April 13, 2020

Etrasimod in Controlled Release Seen to Limit Heart Rate Changes, May Be Added to Trials

News

A controlled-release version of etrasimod could limit the changes in heart rate linked to an initial dose of this investigational medication, according to topline clinical trial data announced by ... Read more

April 6, 2020April 6, 2020

Scientists Identify Biomarkers, Environmental Factors That May Lead to IBD Prevention

News

Researchers at Mount Sinai have identified new protein biomarkers of Crohn’s disease, and environmental factors that may increase a person’s risk of developing inflammatory bowel disease (IBD). Together, these ... Read more